The September 9 hearing on vaccine safety led by Sen. Ron Johnson (R-Wis.) exposed what many Americans are now beginning to realize: the medical community has arguably been duped into believing that vaccines are unequivocally safe. The hearing, titled “How the Corruption of Science has Impacted Public Perception and Policies Regarding Vaccines,” was led by Johnson’s Permanent Subcommittee on Investigations. It followed other hearings conducted by Johnson on the subject of COVID-19 pandemic and the COVID-19 mRNA shots.
Three witnesses — physician Dr. Jake Scott, attorney Aaron Siri, and Stanford infectious diseases researcher Dr. Toby Rogers, with Scott defending vaccine research and trials and Siri and Rogers questioning them — offered sharply divergent pictures on the reliability of vaccine research and, by extension, vaccine safety. Both camps cited data, but Siri and Rogers proved to be the more nimble and better-informed interpreters of the evidence. Taken together, their testimony reinforced the growing impression that vaccines have never been subjected to the kind of rigorous study the public assumes.
Importantly, the committee put into the public record two irreconcilable records about how vaccine safety should be demonstrated. Siri submitted to the committee an unpublished study conducted inside Henry Ford Health in Detroit. The Ford study contends that real-world comparison is the most meaningful. It studied two cohorts over time, vaccinated vs. unvaccinated children, showing large, repeated signals of vaccine harm in the Ford health system.
The study tracked 18,468 children from birth within the Henry Ford system (1,957 unvaccinated, 16,511 who received at least one vaccine). Using Cox proportional hazard models, the analysis found that vaccination exposure was independently associated with elevated risks across several outcomes: any chronic condition (HR 2.53, 95% CI 2.16–2.96), asthma (HR 4.25, 3.23–5.59), autoimmune disease (HR 4.79, 1.36–16.94), atopic disease (HR 3.03, 2.01–4.57), eczema (HR 1.31, 1.13–1.52), and neurodevelopmental disorder (HR 5.53, 2.91–10.51).